Life Saving Drugs Program (LSDP) Laronidase (Aldurazyme) Evaluation

Project Member(s): Goodall, S., De Abreu Lourenco, R., Lewandowska, M., Addo, R.

Funding or Partner Organisation: Commonwealth Department of Health and Aged Care (Commonwealth Department of Health and Aged Care: C)
Commonwealth Department of Health and Aged Care (Commonwealth Department of Health and Aged Care: C)

Start year: 2020

Summary: This evaluation involves systematic literature reviews to address the questions in the review protocol. This will need to consider what was presented to the PBAC (and any update since then), analysis of LSDP clinical data and dispensing data, and development of a simple cost per Life Year Gained (LYG) economic model using the LSDP data (or amendment of the economic model seen by PBAC, if appropriate).

FOR Codes: Health economics , Health Economics, Evaluation of Health Outcomes

Acknowledgement of Country

UTS acknowledges the Gadigal people of the Eora Nation, the Boorooberongal people of the Dharug Nation, the Bidiagal people and the Gamaygal people, upon whose ancestral lands our university stands. We would also like to pay respect to the Elders both past and present, acknowledging them as the traditional custodians of knowledge for these lands.